Gelonghui March 19 | Kingsley Biotechnology (01548.HK) announced that Legend Biotechnology Co., Ltd. (a non-wholly-owned subsidiary of the company) released its first Environmental, Social and Governance (ESG) report on March 19, 2024.
The ESG report provides an overview of Legend Biotech's ESG plans and reports that meet the Sustainable Accounting Standards Committee's biotechnology and pharmaceutical industry standards, Legend Biotech's ESG data collection and disclosure roadmap, and future growth areas of its ESG path. The ESG report highlights Legendary Biotech's commitment to patients, employees, and communities, and marks a fundamental step on the ESG path and looks forward to continuing in the next few years.